Trial Profile
Clinical Study of Resveratrol on Drug and Carcinogen Metabolizing Enzymes
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Resveratrol (Primary)
- Indications Cancer metastases; Colorectal cancer; Multiple myeloma; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 18 Sep 2009 Actual end date (July 2009) added as reported by ClinicalTrials.gov
- 18 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 03 Dec 2008 Status changed from recruiting to active, no longer recruiting, based on information from ClinicalTrials.gov.